Suppr超能文献

[2010 - 2013年从圣彼得堡儿童中分离出的肺炎链球菌的抗生素耐药性和血清型模式]

[Antibiotic Resistance and Serotype Pattern of Streptococcus pneumoniae Isolated from Children in St. Petersburg in 2010-2013].

作者信息

Kalinogorskaya O S, Belanov S S, Volkova M O, Gostev V V, Sidorenko S V

出版信息

Antibiot Khimioter. 2015;60(1-2):10-8.

Abstract

The surveillance of the serotype pattern and antibiotic resistance of S. pneumoniae in various geographical regions is required for the validity of rational etiotrophic therapy of pneumococcal infections and the choice of the optimal vaccines for their prophylaxis. 250 S. pneumoniae isolates from children with acute otitis or pneumonia and healthy carriers in St. Petersburg in 2010-2013 were investigated. The analysis of the serotype pattern of the pneumococci showed that 13-valent conjugate vaccine was the most active (86.1% of pneumococci causing pneumonia and 86.4% of pneumococci causing acute otitis). The isolates were higly resistant to beta-lactams and macrolides. By the EUCAST criteria, the decrease in the susceptibility to penicillin, cefotaxime, erythromycin and ceftarolin was observed in 32.4%, 14%, 33.2 and 6% of the isolates respectively. 22.4% of the isolates showed associate resistance to penicillin and erythromycin.. No resistance to moxifloxacin was detected. The frequency of resistance to tetracycline, co-trimoxasole and chloramphenicol in various patients ranged within 30-50%. The prevalence of the antibiotic resistance was mainly characteristic of the isolates serotypes 19A, 19F, 14 and serogroup 6.

摘要

为了使肺炎球菌感染的合理病因治疗有效并选择最佳预防疫苗,需要对不同地理区域肺炎链球菌的血清型模式和抗生素耐药性进行监测。对2010 - 2013年圣彼得堡患有急性中耳炎或肺炎的儿童及健康携带者的250株肺炎链球菌分离株进行了研究。肺炎球菌血清型模式分析表明,13价结合疫苗活性最高(引起肺炎的肺炎球菌中有86.1%,引起急性中耳炎的肺炎球菌中有86.4%)。分离株对β-内酰胺类和大环内酯类高度耐药。根据欧盟CAST标准,分别在32.4%、14%、33.2%和6%的分离株中观察到对青霉素、头孢噻肟、红霉素和头孢洛林的敏感性下降。22.4%的分离株对青霉素和红霉素表现出联合耐药。未检测到对莫西沙星的耐药性。不同患者中对四环素、复方新诺明和氯霉素的耐药频率在30% - 50%之间。抗生素耐药性的流行主要特征为19A、19F、14血清型及6血清群的分离株。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验